Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgenetic Alopecia (AGA)”

Showing 20 of 0 results

Not applicableStudy completedNCT07433933
What this trial is testing

Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.

Who this might be right for
Telogen EffluviumAndrogenetic Alopecia
Lacer S.A. 40
Testing effectiveness (Phase 2)Study completedNCT02170662
What this trial is testing

Topical Bimatoprost Effect on Androgen Dependent Hair Follicles

Who this might be right for
Male Pattern Hair LossAndrogenetic Alopecia
Duke University 33
Early research (Phase 1)Study completedNCT02824380
What this trial is testing

Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia

Who this might be right for
Androgenic Alopecia
Dong-A ST Co., Ltd. 14
Not applicableStudy completedNCT02460497
What this trial is testing

Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia

Who this might be right for
Female Pattern Hair Loss, Androgenic Alopecia
Galderma R&D 61
Early research (Phase 1)Study completedNCT04913519
What this trial is testing

TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)

Who this might be right for
Alopecia, Androgenetic
Technoderma Medicines Inc. 30
Not applicableStudy completedNCT02067260
What this trial is testing

A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males

Who this might be right for
Androgenetic Alopecia
Spencer Forrest, Inc.
Not applicableWithdrawnNCT04882969
What this trial is testing

Thulium Laser and KeraFactor for the Treatment of Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
Montefiore Medical Center
Large-scale testing (Phase 3)Study completedNCT01231607
What this trial is testing

Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
GlaxoSmithKline 917
Very early researchStudy completedNCT03376581
What this trial is testing

The Utility of Platelet Rich Plasma in Hair Loss

Who this might be right for
Androgenetic Alopecia
University of California, Irvine 30
Not applicableStudy completedNCT02206802
What this trial is testing

Minoxidil Response Testing in Females With Female Pattern Hair Loss

Who this might be right for
AlopeciaFemale Pattern Hair Loss
Applied Biology, Inc. 300
Early research (Phase 1)Study completedNCT04502901
What this trial is testing

The Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose Ascending

Who this might be right for
Androgenetic Alopecia
Suzhou Kintor Pharmaceutical Inc, 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07529977
What this trial is testing

Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

Who this might be right for
Androgenetic AlopeciaAndrogenetic Alopecia (AGA)
Eurofarma Laboratorios S.A. 372
Early research (Phase 1)Study completedNCT02791243
What this trial is testing

Photosensitization Study in Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
Polichem S.A. 58
Testing effectiveness (Phase 2)Study completedNCT04774874
What this trial is testing

A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers

Who this might be right for
Androgenetic Alopecia
Follicum AB 209
Early research (Phase 1)UnknownNCT02154503
What this trial is testing

Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
Vancouver General Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05888922
What this trial is testing

Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

Who this might be right for
Androgenetic AlopeciaFemale Pattern Baldness
Industrial Farmacéutica Cantabria, S.A. 520
Large-scale testing (Phase 3)Study completedNCT05989165
What this trial is testing

Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men

Who this might be right for
Androgenetic Alopecia
Universitas Indonesia 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT07303322
What this trial is testing

Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)

Who this might be right for
Female Pattern Hair LossFemale Pattern Hair Loss, Androgenic Alopecia
Eurofarma Laboratorios S.A. 372
Not applicableUnknownNCT06218394
What this trial is testing

Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
Second Affiliated Hospital, Zhejiang University, School of Medicine 135
Post-approval studies (Phase 4)WithdrawnNCT02483195
What this trial is testing

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

Who this might be right for
Female Androgenetic Alopecia
University of Florida
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation